Remodeling of these secretory pathways during inflammation may contribute to disease and provide therapeutic targets to alleviate specific pathology, such as the role of A1AT misfolding and accumulation in hepatocytes in liver cirrhosis. The gene discussed is SERPINA1; the disease is cirrhosis of liver.